These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 17145872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
    Chaffer CL, Dopheide B, Savagner P, Thompson EW, Williams ED.
    Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors.
    Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC.
    Clin Cancer Res; 2007 Mar 15; 13(6):1685-94. PubMed ID: 17363521
    [Abstract] [Full Text] [Related]

  • 6. Modulation of several waves of gene expression during FGF-1 induced epithelial-mesenchymal transition of carcinoma cells.
    Billottet C, Tuefferd M, Gentien D, Rapinat A, Thiery JP, Broët P, Jouanneau J.
    J Cell Biochem; 2008 Jun 01; 104(3):826-39. PubMed ID: 18189245
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D, Ramos-Vara JA, Stewart JC, Zheng R, Knapp DW.
    Urol Oncol; 2009 Jun 01; 27(3):284-92. PubMed ID: 18562222
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between E-cadherin and fibroblast growth factor receptor 2b expression in bladder carcinomas.
    De Medina SG, Popov Z, Chopin DK, Southgate J, Tucker GC, Delouvée A, Thiery JP, Radvanyi F.
    Oncogene; 1999 Oct 07; 18(41):5722-6. PubMed ID: 10523852
    [Abstract] [Full Text] [Related]

  • 13. [Epithelial-mesenchymal transition in cancer progression].
    Gos M, Miłoszewska J, Przybyszewska M.
    Postepy Biochem; 2009 Oct 07; 55(2):121-8. PubMed ID: 19824467
    [Abstract] [Full Text] [Related]

  • 14. Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases.
    Thomas-Mudge RJ, Okada-Ban M, Vandenbroucke F, Vincent-Salomon A, Girault JM, Thiery JP, Jouanneau J.
    Oncogene; 2004 Jun 10; 23(27):4771-9. PubMed ID: 15122340
    [Abstract] [Full Text] [Related]

  • 15. Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents.
    Vargha R, Endemann M, Kratochwill K, Riesenhuber A, Wick N, Krachler AM, Malaga-Dieguez L, Aufricht C.
    Nephrol Dial Transplant; 2006 Oct 10; 21(10):2943-7. PubMed ID: 16861732
    [Abstract] [Full Text] [Related]

  • 16. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
    Li GC, Wang ZY.
    Anticancer Res; 2006 Oct 10; 26(5A):3555-60. PubMed ID: 17094482
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
    Wu K, Zeng J, Li L, Fan J, Zhang D, Xue Y, Zhu G, Yang L, Wang X, He D.
    Oncol Rep; 2010 Jun 10; 23(6):1545-52. PubMed ID: 20428808
    [Abstract] [Full Text] [Related]

  • 19. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT, Henriquez NV, van Overveld PG, van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clézardin P, Papapoulos SE, Cecchini MG, Löwik CW, van der Pluijm G.
    Cancer Res; 2007 Sep 15; 67(18):8742-51. PubMed ID: 17875715
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.